|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 725 15TH STREET, NW, #500 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Rolling Meadows |
State | IL |
Zip Code | 60008 |
Country | USA |
|
5. Senate ID# 1648-12
|
||||||||
|
6. House ID# 338710000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Katherine O. Orrico, Director, Washington Office |
Date | 10/20/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Appropriations for Emergency Medical Services for Children (EMSC)
Appropriations for Title XII of the Public Health Service Act, trauma care system planning and development, at the level of $12 million in the Fiscal Year (FY) 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Roberts |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Medical Malpractice Alternatives Act of 2009 federal funding for state grants for medical liability reform demonstration projects.
H.R 2502 -- Comparative Effectiveness Research Act of 2009 supporting the establishing an independent institute for comparative effective research that focuses on clinical not cost effectiveness
HR 3200 Americas Affordable Health Choices Act healthcare reform including: Medicare physician payment reform, independent Medicare Commission, surgical workforce, graduate medical education, medical liability reform, emergency-trauma care improvements, budget-neutral primary care bonus payments, physician resource use outliers, comparative effectiveness research, physician quality improvement programs, accountable care organizations, medical student loan debt forgiveness, reimbursement for imaging, public health insurance option, eliminating preexisting condition insurance clauses, expanding coverage of the uninsured, physician ownership of specialty hospitals, physician-industry relationships
No Bill Urging the establishment of a pathway for biosimilars/follow on biologics,
S. 1213 -- Patient-Centered Outcomes Research Act of 2009 -- supporting the establishing an independent institute for comparative effective research that focuses on clinical not cost effectiveness
S. 1679, Affordable Health Choices Act -- healthcare reform including: Medicare physician payment reform, independent Medicare Commission, surgical workforce, graduate medical education, medical liability reform, emergency-trauma care improvements, budget-neutral primary care bonus payments, physician resource use outliers, comparative effectiveness research, physician quality improvement programs, accountable care organizations, medical student loan debt forgiveness, reimbursement for imaging, public health insurance option, eliminating preexisting condition insurance clauses, expanding coverage of the uninsured, physician ownership of specialty hospitals, physician-industry relationships
S. 1796, Americans Healthy Future Act -- healthcare reform including: Medicare physician payment reform, independent Medicare Commission, surgical workforce, graduate medical education, medical liability reform, emergency-trauma care improvements, budget-neutral primary care bonus payments, physician resource use outliers, comparative effectiveness research, physician quality improvement programs, accountable care organizations, medical student loan debt forgiveness, reimbursement for imaging, public health insurance option, eliminating preexisting condition insurance clauses, expanding coverage of the uninsured, physician ownership of specialty hospitals, physician-industry relationships
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Roberts |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 2718 -- Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 opposing creation of independent MedPAC with authority to make changes to Medicare program without approval of Congress
H.R. 2844, the Medicare Payment Improvement Act of 2009 Opposing establishment of value index for Medicare physician reimbursement
H.R 2502 -- Comparative Effectiveness Research Act of 2009 supporting the establishing an independent institute for comparative effective research that focuses on clinical not cost effectiveness
H.R. 2962, the Integrity in Medicare Advanced Diagnostic Imaging Act of 2009 opposing limits on physician ownership and self-referral of diagnostic imaging equipment/services.
HR 3200 Americas Affordable Health Choices Act healthcare reform including: Medicare physician payment reform, independent Medicare Commission, surgical workforce, graduate medical education, medical liability reform, emergency-trauma care improvements, budget-neutral primary care bonus payments, physician resource use outliers, comparative effectiveness research, physician quality improvement programs, accountable care organizations, medical student loan debt forgiveness, reimbursement for imaging, public health insurance option, eliminating preexisting condition insurance clauses, expanding coverage of the uninsured, physician ownership of specialty hospitals, physician-industry relationships
S. 1110 -- Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 opposing creation of independent MedPAC with authority to make changes to Medicare program without approval of Congress
S. 1213 -- Patient-Centered Outcomes Research Act of 2009 -- supporting the establishing an independent institute for comparative effective research that focuses on clinical not cost effectiveness
S. 1380 -- Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 opposing creation of independent MedPAC with authority to make changes to Medicare program without approval of Congress
S. 1679, Affordable Health Choices Act -- healthcare reform including: Medicare physician payment reform, independent Medicare Commission, surgical workforce, graduate medical education, medical liability reform, emergency-trauma care improvements, budget-neutral primary care bonus payments, physician resource use outliers, comparative effectiveness research, physician quality improvement programs, accountable care organizations, medical student loan debt forgiveness, reimbursement for imaging, public health insurance option, eliminating preexisting condition insurance clauses, expanding coverage of the uninsured, physician ownership of specialty hospitals, physician-industry relationships
S. 1796, Americans Healthy Future Act -- healthcare reform including: Medicare physician payment reform, independent Medicare Commission, surgical workforce, graduate medical education, medical liability reform, emergency-trauma care improvements, budget-neutral primary care bonus payments, physician resource use outliers, comparative effectiveness research, physician quality improvement programs, accountable care organizations, medical student loan debt forgiveness, reimbursement for imaging, public health insurance option, eliminating preexisting condition insurance clauses, expanding coverage of the uninsured, physician ownership of specialty hospitals, physician-industry relationships
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katherine |
Orrico |
|
|
|
Adrienne |
Roberts |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |